241820 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
PCL, Inc. engages in the manufacturing of medical devices. Its products include Blood Testing Kit-Hi3, Ai, Cancer6, SolB Reagent, SolB Desktop Arrayer, and sciFLEXARRAYER. It also offers SG Cap Drug Target ID Service and Sol-Gel Spotting Service. The company was founded on February 12, 2008 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
241820 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company